These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 23490994

  • 1. The bone marrow microenvironment in Waldenström macroglobulinemia.
    Agarwal A, Ghobrial IM.
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):218-21. PubMed ID: 23490994
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The bone marrow niche in Waldenström's macroglobulinemia.
    Ghobrial IM, Zhang Y, Liu Y, Ngo H, Azab F, Sacco A, Azab A, Maiso P, Morgan B, Quang P, Issa G, Roccaro A.
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):118-20. PubMed ID: 21454209
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenström macroglobulinemia.
    Muz B, de la Puente P, Azab F, Ghobrial IM, Azab AK.
    Mol Cancer Res; 2015 Feb; 13(2):263-72. PubMed ID: 25232031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New insights into the pathogenesis and treatment of Waldenstrom macroglobulinemia.
    Issa GC, Leblebjian H, Roccaro AM, Ghobrial IM.
    Curr Opin Hematol; 2011 Jul; 18(4):260-5. PubMed ID: 21519243
    [Abstract] [Full Text] [Related]

  • 9. Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies.
    Boutilier AJ, Huang L, Elsawa SF.
    Int J Mol Sci; 2022 Sep 22; 23(19):. PubMed ID: 36232447
    [Abstract] [Full Text] [Related]

  • 10. Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia.
    Sun H, Fang T, Wang T, Yu Z, Gong L, Wei X, Wang H, He Y, Liu L, Yan Y, Sui W, Xu Y, Yi S, Qiu L, Hao M.
    J Transl Med; 2022 Dec 09; 20(1):576. PubMed ID: 36494694
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-kappaB activation.
    Merzianu M, Jiang L, Lin P, Wang X, Weber DM, Vadhan-Raj S, Nguyen MH, Medeiros LJ, Bueso-Ramos CE.
    Mod Pathol; 2006 Jul 09; 19(7):891-8. PubMed ID: 16636680
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia.
    Leleu X, Xu L, Jia X, Sacco A, Farag M, Hunter ZR, Moreau AS, Ngo HT, Hatjiharissi E, Ho AW, Santos DD, Adamia S, O'Connor K, Ciccarelli B, Soumerai J, Manning RJ, Patterson CJ, Roccaro AM, Ghobrial IM, Treon SP.
    Blood; 2009 Jan 15; 113(3):626-34. PubMed ID: 18981296
    [Abstract] [Full Text] [Related]

  • 17. The epidemiology of Waldenström macroglobulinemia.
    McMaster ML.
    Semin Hematol; 2023 Mar 15; 60(2):65-72. PubMed ID: 37099032
    [Abstract] [Full Text] [Related]

  • 18. Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling.
    Tournilhac O, Santos DD, Xu L, Kutok J, Tai YT, Le Gouill S, Catley L, Hunter Z, Branagan AR, Boyce JA, Munshi N, Anderson KC, Treon SP.
    Ann Oncol; 2006 Aug 15; 17(8):1275-82. PubMed ID: 16788002
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Waldenström macroglobulinemia.
    Treon SP, Hunter ZR, Castillo JJ, Merlini G.
    Hematol Oncol Clin North Am; 2014 Oct 15; 28(5):945-70. PubMed ID: 25212891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.